Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization

Brain Research

Volumn 1145, Issue 1, 2007, Pages 66-80

  Yang, Pamela B ^a   Swann, Alan C ^b   Dafny, Nachum ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Caudate nucleus; Electrophysiology; Evoked potential; Prefrontal cortex; Psychostimulant; Sensitization

Indexed keywords

METHYLPHENIDATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG EFFECT; ELECTROPHYSIOLOGY; EVOKED SOMATOSENSORY RESPONSE; LOCOMOTION; MALE; NEUROPHYSIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVOKED POTENTIALS; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, INBRED WKY; SENSORY THRESHOLDS;

ANIMALIA; RATTUS;

EID: 33947648513     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.108     Document Type: Article

References (87)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., and Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52 (1989) 1655-1658
2. Accardo P., and Blondis T.A. What's all the fuss about Ritalin?. J. Pediatr. 138 (2001) 6-9
3. Aldridge J.W., and Berridge K.C. Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J. Neurosci. 18 (1998) 2777-2787
4. Anderson J.C., Williams S., McGee R., and Silva P.A. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch. Gen. Psychiatry 44 (1987) 69-76
5. Arnsten A.F., Steere J.C., and Hunt R.D. The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53 (1996) 448-455
6. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., and Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat. Neurosci. 6 (2003) 115-116
7. Barbaresi W., Katusic S., Colligan R., Oankratz V., Weber K., et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch. Pediatr. Adolesc. Med. 156 (2002) 217-224
8. Biederman J., Faraone S.V., Spencer T., Wilens T., Mick E., and Lapey K.A. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 53 (1994) 13-29
9. Bunney B.S., Walters J.R., Roth R.H., and Aghajanian G.K. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185 (1973) 560-571
10. Bush G., Valera E.M., and Seidman L.J. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 57 (2005) 1273-1284
11. Carboni E., Tanda G.L., Frau R., and Di Chiari G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55 (1990) 1067-1070
12. Carlezon W.A., and Konradi C. Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology 47 (2004) 47-60
13. Challman T.D., and Lipsky J.J. Methylphenidate: its pharmacology and uses. Mayo Clin. Proc. 75 (2000) 711-721
14. Crawford C.A., McDougal S.A., Meier T.L., Collins R.L., and Watson J.B. Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology 136 (1998) 34-43
15. Dafny N. Catecholamine-modulated field potentials in the hypothalamus. Neuroendocrinology 18 (1975) 42-54
16. Dafny N. Effect of substantia nigra stimulation on spontaneous unit activity in the caudate nucleus. Exp. Neurol. 47 (1975) 503-508
17. Dafny N. Electrophysiological properties of caudate neurons following substantia nigra, motor cortex, and amygdaloid nuclear complex stimulation of the rat. Appl. Neurophysiol. 38 (1975) 259-272
18. Dafny N. Neurophysiological approach as a tool to study the effects of drugs on the central nervous system: dose effect of pentobarbital. Exp. Neurol. 59 (1978) 263-274
19. Dafny N. Is interferon-alpha a neuromodulator?. Brain Res. Rev. 26 (1998) 1-15
20. Dafny N., and Feldman S. Single cell activity in the hypothalamus in intact and adrenalectomized rats. Physiol. Behav. 5 (1970) 873-878
21. Dafny N., and Gildenberg P. Morphine effects on spontaneous, nociceptive, antinociceptive and sensory evoked responses of parafasciculus thalami units in morphine naive and morphine dependent rats. Brain Res. 323 (1984) 11-20
22. Dafny N., and Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res. Bull. 68 (2006) 393-405
23. Dafny N., Dauth G., and Gilman S. Differential effects of agents which alter CNS monoamine levels upon acoustic responses in the basal ganglia of freely moving rats. Int. J. Neurol. 10 (1975) 53-67
24. Dafny N., Marchand J., McClung R., Salamy J., Sands S., Wachtendorf H., and Burks T.F. Effects of morphine on sensory-evoked responses recorded from central gray, reticular formation, thalamus, hypothalamus, limbic system, basal ganglia, dorsal raphe, locus ceruleus, and pineal body. J. Neurosci. Res. 5 (1981) 399-412
25. Duncan J., and Owen A.M. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci. 23 (2000) 475-483
26. Eichlseder W. Ten years of experience with 1,000 hyperactive children in a private practice. Pediatria 76 (1985) 176-184
27. Einhorn L.C., Johansen P.A., and White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 8 (1988) 100-112
28. Emson P.C., and Koob G.F. The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res. 142 (1978) 249-267
29. Garris P.A., and Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14 (1994) 442-450
30. Gaytan O., Al-Rahim S., Swann A., and Dafny N. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Life Sci. 61 (1997) PL101-PL107
31. Gaytan O., Ghelani D., Martin S., Swann A., and Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 777 (1997) 1-12
32. Gittelman R., Marmuzza S., Shcnker R., and Bonagura N. Hyperactive boys almost grown up: I. Psychiatric status. Arch. Gen. Psychiatry 42 (1985) 937-947
33. Goeders N.E., and Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science 221 (1983) 773-775
34. Greenhill L.L. Clinical effects of stimulant medication in attention deficit/hyperactivity disorder (ADHD). In: Solanto M.V., Arnsten A.F.T., and Castellanos F.X. (Eds). Stimulant Drugs and ADHD: Basic and Clinical Neuroscience (2001), Oxford UP, New York 31-71
35. Gresch P.J., Sved A.F., Zigmond M.J., and Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem. 65 (1995) 111-116
36. Himelstein J., and Halperin J.M. Identification of AD/HD subtypes using laboratory-based measures: a cluster analysis. CNS Spectrums 5 (2000) 58-64
37. Izenwasser S., Coy A.E., Ladenheim B., Loeloff R.J., Cadet J.L., and French D. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur. J. Pharmacol. 373 (1999) 187-193
38. Kalivas P.W., and Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5 (1990) 48-58
39. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16 (1991) 223-244
40. Kalivas P.W., Pierce R.C., Cornish J., and Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12 (1998) 49-53
41. Kaufmann M.W., Cassem N.H., Murray G.B., and Jenike M. Use of psychostimulants in medically ill patients with neurological disease and major depression. Can. J. Psychiatry 29 (1984) 46-49
42. Kollins S.H., MacDonald E.K., and Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav. 68 (2001) 611-627
43. Kuczenski R., and Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J. Pharmacol. Exp. Ther. 296 (2001) 876-883
44. Kuczenski R., and Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22 (2002) 7264-7271
45. Laviola G., Adriani W., Terranova M.L., and Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci. Biobehav. Rev. 23 (1999) 993-1010
46. Leith N.J., and Kuczenski R. Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology (Berlin) 76 (1982) 310-315
47. Lindholm E., and Koriath J.J. Analysis of multiple event related potential components in a tone discrimination task. Int. J. Psychophysiol. 3 (1985) 121-129
48. MacDonald E.K., and Kollins S.H. Assessing the reinforcing effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder using a choice procedure. Drug Alcohol Depend. 60 (2000) S134
49. MacDonald F.E., and Kollins S.H. A pilot study of methylphenidate preference assessment in children diagnosed with attention deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 15 (2005) 729-741
50. Mazei M.S., Pluto C.P., Kirkbride B., and Pehek E.A. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res. 936 (2002) 58-67
51. McNamara C.G., Davidson E.S., and Schenk S. A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacol. Biochem. Behav. 45 (1993) 729-732
52. Michie P.T., Fox A.M., Ward S.V., Catts N., and McConaghy N. Event-related potential indices of selective attention and cortical lateralization in schizophrenia. Psychophysiology 27 (1990) 209-227
53. Miserendino M.J.D., and Nestler E.J. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 674 (1995) 299-306
54. Musser C.J., Ahmann F.W., Mundt P., Broste S.K., and Mueller-Rizner N. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J. Dev. Behav. Pediatr. 19 (1998) 187-192
55. Nakamura T., Ghilardi M.F., Mentis M., et al. Hum. Brain Mapp. 12 (2001) 42-60
56. National Institutes of Health Consensus Development Conference Statement (NIHCDCS). J. Am. Acad. Child Adolesc. Psych. 39 (2000) 182-193
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, New York
58. Picton T.W., Bentin S., Berg P., Donchin E., Hillyard R., and Johnson R. Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria. Psychophysiology 37 (2000) 127-152
59. Pierce C.R., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25 (1997) 192-216
60. Pozzi L., Invernizzi R., Cervo L., Vallebuona F., and Samanin R. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63 (1994) 195-200
61. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
62. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. 18 (1993) 247-291
63. Robinson T.E., Jurson P.A., Bennett J.A., and Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462 (1988) 211-222
64. Rowland A., Umbach D., Catoe K., Stallone L., Long S., Rabiner D., et al. Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Can. J. Pyschiatry 46 (2001) 931-940
65. Rubia K., Overmeyer S., Taylor E., Brammer M., Williams S.C., Simmons A., et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am. J. Psychiatry 156 (1999) 891-896
66. Ruskin D.N., Bergstrom D.A., Shenker A., Freeman L.E., Baek D., and Walters J.R. Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action. Biol. Psychiatry 49 (2001) 340-350
67. Segal D.S., and Kuczenski R. Behavioral and neurochemical characteristics of stimulant-induced augmentation. Psychopharmacol. Bull. 23 (1987) 417-424
68. Segal D.S., and Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571 (1992) 330-337
69. Seidman L.J., Valera E.M., and Bush G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am. 27 (2004) 323-347
70. Sergeant J.A., Geurts H., and Oosterlaan J. How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?. Behav. Brain Res. 130 (2002) 3-28
71. Shi W.X., Pun C.L., Smith P.L., and Bunney B.S. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors. Synapse 35 (2000) 111-119
72. Shi W.X., Pun C.L., and Zhou Y. Psychostimulants induce low-frequency oscillations in the firing activity of dopamine neurons. Neuropsychopharmacology 29 (2004) 2160-2167
73. Slopsema J.S., Van Der Gugten J., and DeBruin J.P.C. Regional concentrations of noradrenaline and dopamine in the frontal cortex of the rat: dopaminergic innervation of the prefrontal subareas and lateralization of prefrontal dopamine. Brain Res. 250 (1982) 197-200
74. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94 (1998) 127-152
75. Solowij N., Michie P.T., and Fox A.M. Effects of long-term cannabis use on selective attention: an event-related potential study. Pharmacol. Biochem. Behav. 40 (1991) 683-688
76. Steketee J.D. Intra-A10 injection of H7 blocks the development of sensitization to cocaine. NeuroReport 6 (1994) 69-72
77. Steketee J.D., Striplin C.D., Murray T.F., and Kalivas P.W. Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res. 545 (1991) 287-291
78. Swanson J.M., and Volkow N.D. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav. Brain Res. 130 (2002) 73-78
79. Swanson J.M., Gupta S., Guinta D., Flynn D., Agler D., Lerner M., Williams L., Shoulson I., and Wigal S. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin. Pharmacol. Ther. 66 (1999) 295-305
80. Teo R.K., and Ferguson D.A. The acute effects of ethanol on auditory event-related potentials. Psychopharmacology (Berlin) 90 (1986) 179-184
81. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605 (1993) 332-337
82. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987) 660-669
83. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 5 (1998) 141-153
84. Winsberg B.G., Javitt D.C., and Shanahan/Silipo G. Electrophysiological indices of information processing in methylphenidate responders. Biol. Psychiatry 42 (1997) 434-445
85. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54 (1998) 679-720
86. Yang P.B., Amini B., Swann A.C., and Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 971 (2003) 139-152
87. Yang P.B., Swann A.C., and Dafny N. Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behav. Brain Funct. 2 (2006) 3